Changes in fecal pellet characteristics with depth as indicators of zooplankton repackaging of particles in the mesopelagic zone of the subtropical and subarctic North Pacific Ocean

Author Posting. © Elsevier B.V., 2008. This is the author's version of the work. It is posted here by permission of Elsevier B.V. for personal use, not for redistribution. The definitive version was published in Deep Sea Research Part II: Topical Studies in Oceanography 55 (2008): 1636-1647, doi:10.1016/j.dsr2.2008.04.019.We investigated how fecal pellet characteristics change with depth in order to quantify the extent of particle repackaging by mesopelagic zooplankton in two contrasting open-ocean systems. Material from neutrally buoyant sediment traps deployed in the summer of 2004 and 2005 at 150, 300, and 500 m was analyzed from both a mesotrophic (Japanese time-series station K2) and an oligotrophic (Hawaii Ocean Time series-HOT station ALOHA) environment in the Pacific Ocean as part of the VERtical Transport In the Global Ocean (VERTIGO) project. We quantified changes in the flux, size, shape, and color of particles recognizable as zooplankton fecal pellets to determine how these parameters varied with depth and location. Flux of K2 fecal pellet particulate organic carbon (POC) at 150 and 300 m was 4-5 times higher than at ALOHA, and at all depths, fecal pellets were 2-5 times larger at K2, reflective of the disparate zooplankton community structure at the two sites. At K2, the proportion of POC flux that consisted of fecal pellets generally decreased with depth from 20% at 150 m to 5% at 500 m, whereas at ALOHA this proportion increased with depth (and was more variable) from 14% to 35%. This difference in the fecal fraction of POC with increasing depth is hypothesized to be due to differences in the extent of zooplankton-mediated fragmentation (coprohexy) and in zooplankton community structure between the two locations. Both regions provided indications of sinking particle repackaging and zooplankton carnivory in the mesopelagic. At ALOHA this was reflected in a significant increase in the mean flux of larvacean fecal pellets from 150 to 500 m of 3 to 46 μg C m-2 d-1, respectively, and at K2 a large peak in larvacean mean pellet flux at 300 m of 3.1 mg C m-2 d-1. Peaks in red pellets produced by carnivores occurred at 300 m at K2, and a variety of other fecal pellet classes showed significant changes in their distribution with depth. There was also evidence of substantially higher pellet fragmentation at K2 with nearly double the ratio of broken:intact pellets at 150 and 300 m (mean of 67% and 64%, respectively ) than at ALOHA where the proportion of broken pellets remained constant with depth (mean 35%). Variations in zooplankton size and community structure within the mesopelagic zone can thus differentially alter the transfer efficiency of sinking POC.This study was supported by grants from the U.S. National Science Foundation NSF OCE-0324402 (Biological Oceanography) to D.K.S and OCE-0301139 (Chemical Oceanography) to K.O.B

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.

BACKGROUND: Remote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown to reduce myocardial infarct size in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). We investigated whether remote ischaemic conditioning could reduce the incidence of cardiac death and hospitalisation for heart failure at 12 months. METHODS: We did an international investigator-initiated, prospective, single-blind, randomised controlled trial (CONDI-2/ERIC-PPCI) at 33 centres across the UK, Denmark, Spain, and Serbia. Patients (age >18 years) with suspected STEMI and who were eligible for PPCI were randomly allocated (1:1, stratified by centre with a permuted block method) to receive standard treatment (including a sham simulated remote ischaemic conditioning intervention at UK sites only) or remote ischaemic conditioning treatment (intermittent ischaemia and reperfusion applied to the arm through four cycles of 5-min inflation and 5-min deflation of an automated cuff device) before PPCI. Investigators responsible for data collection and outcome assessment were masked to treatment allocation. The primary combined endpoint was cardiac death or hospitalisation for heart failure at 12 months in the intention-to-treat population. This trial is registered with ClinicalTrials.gov (NCT02342522) and is completed. FINDINGS: Between Nov 6, 2013, and March 31, 2018, 5401 patients were randomly allocated to either the control group (n=2701) or the remote ischaemic conditioning group (n=2700). After exclusion of patients upon hospital arrival or loss to follow-up, 2569 patients in the control group and 2546 in the intervention group were included in the intention-to-treat analysis. At 12 months post-PPCI, the Kaplan-Meier-estimated frequencies of cardiac death or hospitalisation for heart failure (the primary endpoint) were 220 (8·6%) patients in the control group and 239 (9·4%) in the remote ischaemic conditioning group (hazard ratio 1·10 [95% CI 0·91-1·32], p=0·32 for intervention versus control). No important unexpected adverse events or side effects of remote ischaemic conditioning were observed. INTERPRETATION: Remote ischaemic conditioning does not improve clinical outcomes (cardiac death or hospitalisation for heart failure) at 12 months in patients with STEMI undergoing PPCI. FUNDING: British Heart Foundation, University College London Hospitals/University College London Biomedical Research Centre, Danish Innovation Foundation, Novo Nordisk Foundation, TrygFonden

Identifying perfectionism traits in veterinary students

Short communicatio

Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis.

Activated leukocyte cell adhesion molecule (ALCAM) is a cell adhesion molecule found on blood-brain barrier endothelial cells (BBB-ECs) that was previously shown to be involved in leukocyte transmigration across the endothelium. In the present study, we found that ALCAM knockout (KO) mice developed a more severe myelin oligodendrocyte glycoprotein (MOG)35-55-induced experimental autoimmune encephalomyelitis (EAE). The exacerbated disease was associated with a significant increase in the number of CNS-infiltrating proinflammatory leukocytes compared with WT controls. Passive EAE transfer experiments suggested that the pathophysiology observed in active EAE was linked to the absence of ALCAM on BBB-ECs. In addition, phenotypic characterization of unimmunized ALCAM KO mice revealed a reduced expression of BBB junctional proteins. Further in vivo, in vitro, and molecular analysis confirmed that ALCAM is associated with tight junction molecule assembly at the BBB, explaining the increased permeability of CNS blood vessels in ALCAM KO animals. Collectively, our data point to a biologically important function of ALCAM in maintaining BBB integrity

Feminist historical geographies: doing and being

As part of GPC’s 25-year anniversary celebrations, this article explores possibilities and prospects for feminist historical geographies and geographers. Here I define feminist historical geography as scholarship which asks geographical questions of historical material and is informed by feminist theories, approaches and methodologies. Its empirical subject matter is necessarily expansive and diverse, but often has a particular focus on the lives of women and other marginalized groups, and on the ways gender and space were co-constituted. This essay interrogates recent developments within this broad terrain, specifically articles and books published in the period from around 2000 onwards and either appearing in geography journals or written by those self-identifying as geographers. The main exception is work by historians and archaeologists interested in gender, space and place, which is cited here in an attempt to open up new research directions for feminist historical geographers. In what follows, we shuttle across spaces and between scales, roaming from the sites of empire to the intimate geographies of the home, from landscapes and buildings to personal possessions like clothes and letters. Doing so is a deliberate act intended both to demonstrate the liveliness of feminist historical geographies broadly conceived and to counter hierarchical readings of space, society and history with their inherent danger of privileging the public over the private, and the exceptional over the everyday and mundane

Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity

Oncostatin M (OSM) is an IL-6 family member which exerts neuroprotective and remyelination-promoting effects after damage to the central nervous system (CNS). However, the role of OSM in neuro-inflammation is poorly understood. Here, we investigated OSM’s role in pathological events important for the neuro-inflammatory disorder multiple sclerosis (MS). We show that OSM receptor (OSMRβ) expression is increased on circulating lymphocytes of MS patients, indicating their elevated responsiveness to OSM signalling. In addition, OSM production by activated myeloid cells and astrocytes is increased in MS brain lesions. In experimental autoimmune encephalomyelitis (EAE), a preclinical model of MS, OSMRβ-deficient mice exhibit milder clinical symptoms, accompanied by diminished T helper 17 (Th17) cell infiltration into the CNS and reduced BBB leakage. In vitro, OSM reduces BBB integrity by downregulating the junctional molecules claudin-5 and VE-cadherin, while promoting secretion of the Th17-attracting chemokine CCL20 by inflamed BBB-endothelial cells and reactive astrocytes. Using flow cytometric fluorescence resonance energy transfer (FRET) quantification, we found that OSM-induced endothelial CCL20 promotes activation of lymphocyte function-associated antigen 1 (LFA-1) on Th17 cells. Moreover, CCL20 enhances Th17 cell adhesion to OSM-treated inflamed endothelial cells, which is at least in part ICAM-1 mediated. Together, these data identify an OSM-CCL20 axis, in which OSM contributes significantly to BBB impairment during neuro-inflammation by inducing permeability while recruiting Th17 cells via enhanced endothelial CCL20 secretion and integrin activation. Therefore, care should be taken when considering OSM as a therapeutic agent for treatment of neuro-inflammatory diseases such as MS